Amrutanjan Health Care · NSE: AMRUTANJAN · BSE: 590006
Q3 FY24 results · Oct–Dec 2023
Amrutanjan Health Care reported revenue from operations of ₹116.99 crore (up 19.8% from Q3 FY23) and net profit of ₹17.45 crore (up 62.9% from Q3 FY23) for Q3 FY24 (Oct–Dec 2023), on a standalone basis.
| Item | Q3 FY24 | Q3 FY23 | YoY | Q2 FY24 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 116.99 | 97.65 | +19.8% | 99.31 | +17.8% |
| Other income | 3.76 | 3.68 | +2.3% | 3.95 | −4.7% |
| Total income | 120.76 | 101.32 | +19.2% | 103.26 | +16.9% |
| Profit before tax | 23.71 | 14.50 | +63.5% | 9.21 | +157.5% |
| Net profit for the period | 17.45 | 10.71 | +62.9% | 6.85 | +154.8% |
| EPS, basic (₹) | 6.05 | 3.67 | +64.9% | 2.36 | +156.4% |
| Net margin (%) | 14.9 | 11.0 | 6.9 |
Standalone
- Filed with BSE
- 22 Feb 2024, 10:15 IST
- Board meeting
- 09 Feb 2024
- Period
- 01 Oct 2023 to 31 Dec 2023
- Review status
- Unaudited
- Source
- XBRL filing on BSE